- Poster presentation
- Open Access
Diffuse myocardial fibrosis is subclinical and is associated with impaired myocardial deformation characteristics in systemic lupus erythematosus: a cardiovascular magnetic resonance study
Journal of Cardiovascular Magnetic Resonance volume 16, Article number: P307 (2014)
Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder that commonly affects the heart, resulting in a 7 to 9 times greater incidence of cardiovascular disease (CVD) in SLE patients compared to healthy controls. Female patients with SLE between 35 and 44 years old have an incidence of myocardial infarction over 50 times greater than that observed in the Framingham cohort. Diffuse myocardial fibrosis can be detected non-invasively by extracellular volume (ECV) mapping based on pre- and postcontrast T1 measurements using cardiovascular magnetic resonance (CMR). We aimed to detect subclinical diffuse myocardial fibrosis in SLE using CMR T1 mapping.
23 SLE patients (22 female, mean age 41 ± 9 years) and 23 matched controls (22 female, mean age 42 ± 9 years) without previously known cardiovascular disease underwent CMR at 1.5T. CMR evaluation included late gadolinium enhancement (LGE) [IV gadoterate meglumine at 0.15 mmol/kg], T1 mapping pre- and postcontrast, cine, tagging, and T2-weighted imaging.
Regional fibrosis on LGE imaging was found in 5 SLE patients (22%) compared to none of controls. Presence of diffuse myocardial fibrosis in SLE was confirmed by significantly higher precontrast T1 values (981 ± 31 vs. 960 ± 21 ms, p = 0.010), decreased postcontrast T1 values (445 ± 31 vs. 470 ± 24 ms, p = 0.005) and expansion of ECV (31.8 ± 4.1 vs. 28.9 ± 2.0 %, p = 0.004). Diffuse myocardial fibrosis was evident in SLE regardless of the presence of any regional fibrosis. Left ventricular volumes, mass and ejection fraction were similar between SLE patients and controls. However, peak systolic circumferential strain (-17.0 ± 1.6 vs. -19.3 ± 1.1, p < 0.001) and peak diastolic strain rate (79 ± 26 vs. 119 ± 15 s-1, p < 0.001) were impaired in SLE. Presence of diastolic dysfunction is SLE was further supported by larger left atrial diameters (31 ± 5 vs. 26 ± 4 mm, p < 0.001). Abnormal myocardial systolic strain and diastolic strain rate correlated with diffuse myocardial fibrosis indices. There was no evidence of myocardial edema in SLE.
Cardiac involvement is common in SLE patients with no cardiovascular symptoms, and includes both focal and diffuse myocardial fibrosis, which is associated with impaired systolic and diastolic strain parameters. CMR is a robust non-invasive tool for the assessment of diffuse myocardial fibrosis and subclinical cardiac involvement in inflammatory heart disease.
This study was funded by an investigator-led grant from GSK to Dr Theo Karamitsos. The authors gratefully acknowledge support from the National Institute for Health Research Oxford Biomedical Research Centre Programme. Prof. Stefan Neubauer also acknowledges support from the Oxford British Heart Foundation Centre for Research Excellence.
Rights and permissions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Ntusi, N.A., Piechnik, S.K., Francis, J.M. et al. Diffuse myocardial fibrosis is subclinical and is associated with impaired myocardial deformation characteristics in systemic lupus erythematosus: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 16 (Suppl 1), P307 (2014). https://doi.org/10.1186/1532-429X-16-S1-P307
- Systemic Lupus Erythematosus
- Cardiovascular Magnetic Resonance
- Systemic Lupus Erythematosus Patient
- Late Gadolinium Enhancement
- Cardiovascular Magnetic Resonance Study